Tuesday 5/7 Insider Buying Report: NLY, NVUS (Nasdaq.com)
At Annaly Capital Management (NLY), a filing with the SEC revealed that on Monday, Chairman, CEO & President Kevin Keyes bought 300,000 shares of NLY, at a cost of $9.62 each, for a total investment of $2.89M. Annaly Capital Management is trading up about 0.7% on the day Tuesday. And on Thursday, Director Erez Chimovits bought $2.00M worth of Novus Therapeutics (NVUS), buying 646,204 shares at a cost of $3.10 a piece. Novus Therapeutics is trading up about 1.6% on the day Tuesday. Investors can buy NVUS even cheaper than Chimovits did, with the stock changing hands as low as $2.60 at last check today which is 16.1% under Chimovits’s purchase price.
Intuitive Surgical Inc (ISRG) President & CEO Gary S Guthart Sold $11.4 million of Shares (GuruFocus)
President & CEO of Intuitive Surgical Inc (NASDAQ:ISRG) Gary S Guthart sold 22,636 shares of ISRG on 05/06/2019 at an average price of $501.48 a share. The total sale was $11.4 million. Intuitive Surgical Inc designs, manufactures, markets da Vinci Surgical Systems, and related instruments. The da Vinci surgery, combines the benefits of minimally invasive surgery for patients with the ease of use, precision and dexterity of open surgery. Intuitive Surgical Inc has a market cap of $56.73 billion; its shares were traded at around $491.39 with a P/E ratio of 51.13 and P/S ratio of 15.20. Intuitive Surgical Inc had annual average EBITDA growth of 12.40% over the past ten years.
What Did This CEO Just Do with Personal Shares of Idexx Laboratories (NASDAQ: IDXX)? (AnalystRatings.com)
Today, the COB, Pres & CEO of Idexx Laboratories (IDXX), Jonathan Ayers, sold shares of IDXX for $6.97M. Following Jonathan Ayers’ last IDXX Sell transaction on February 22, 2019, the stock climbed by 41.3%. This is Ayers’ first Sell trade following 13 Buy transactions. Based on Idexx Laboratories’ latest earnings report for the quarter ending March 31, the company posted quarterly revenue of $576 million and quarterly net profit of $103 million. In comparison, last year the company earned revenue of $538 million and had a net profit of $89.45 million. IDXX’s market cap is $21.61B and the company has a P/E ratio of 56.54. Currently, Idexx Laboratories has an average volume of 493.5K.
Insider trading: May 7, 2019 (BIV.com)
The following is a list of stock trades made by corporate executives, directors and other company insiders of B.C.’s public companies filed in the week ended May 1, 2019. The information comes from a compilation of required reports filed with the BC Securities Commission obtained from DisclosureNet.com. Insider Jozef Maria Hendrik Raats, 10% owner. Company: Immunoprecise Antibodies Ltd. (TSX-V:IPA). Shares owned: 4,543,130. Trade date: April 26, 29. Trade total: $139,750. Trade: Sale of 172,500 shares at prices ranging between $0.77 and $0.84 per share.
The CEO of Tesla (NASDAQ: TSLA) is Buying Shares (Analyst Ratings)
Yesterday, the CEO of Tesla (TSLA), Elon Musk, bought shares of TSLA for $25M. Based on Tesla’s latest earnings report for the quarter ending March 31, the company posted quarterly revenue of $4.54 billion and GAAP net loss of $702 million. In comparison, last year the company earned revenue of $3.41 billion and had a GAAP net loss of $710 million. Currently, Tesla has an average volume of 10.83M. The Company has a Price to Book ratio of 9.6291.
